Akari Therapeutics ADR (AKTX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2019 | 09-2019 | 06-2019 | 03-2019 | 12-2018 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -16,846 | -9,227,720 | -6,662 | -2,545 | -16,467 |
| Depreciation Amortization | 19 | 14,892 | 10 | 6 | 36 |
| Accounts payable and accrued liabilities | 2,380 | N/A | N/A | 314 | -3,690 |
| Other Working Capital | 3,091 | -1,263,148 | 685 | -151 | -4,455 |
| Other Operating Activity | -1,562 | 1,021,962 | 1,424 | 2,606 | 1,995 |
| Operating Cash Flow | $-12,918 | $-9,454,014 | $-4,544 | $229 | $-22,580 |
| Cash Flows From Investing Activities | |||||
| Investing Cash Flow | $N/A | $N/A | $N/A | $N/A | $N/A |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 12,648 | 9,871,886 | 1,474 | 158 | 306 |
| Financing Cash Flow | $12,648 | $9,871,886 | $1,474 | $158 | $306 |
| Exchange Rate Effect | 34 | -117,172 | -144 | -61 | -7 |
| Beginning Cash Position | 5,968 | 5,967,967 | 5,968 | 5,968 | 28,249 |
| End Cash Position | 5,732 | 6,268,667 | 2,754 | 6,294 | 5,968 |
| Net Cash Flow | $-236 | $300,700 | $-3,214 | $326 | $-22,281 |
| Free Cash Flow | |||||
| Operating Cash Flow | -12,918 | -9,454,014 | -4,544 | 229 | -22,580 |
| Free Cash Flow | -12,918 | -9,454,014 | -4,544 | 229 | -22,580 |